These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 16228292

  • 1. BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53.
    Basma H, El-Refaey H, Sgagias MK, Cowan KH, Luo X, Cheng PW.
    J Biomed Sci; 2005 Dec; 12(6):999-1011. PubMed ID: 16228292
    [Abstract] [Full Text] [Related]

  • 2. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S.
    Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424
    [Abstract] [Full Text] [Related]

  • 3. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K, Takemura K, Kihara M, Naito S, Lee E, Shimizu E, Yamauchi A.
    Oncol Rep; 2005 Jun 01; 13(6):1229-34. PubMed ID: 15870947
    [Abstract] [Full Text] [Related]

  • 4. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
    Lahiry L, Saha B, Chakraborty J, Adhikary A, Mohanty S, Hossain DM, Banerjee S, Das K, Sa G, Das T.
    Carcinogenesis; 2010 Feb 01; 31(2):259-68. PubMed ID: 19969555
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS, Lademann U, Jäättelä M.
    Cancer Res; 1999 Oct 01; 59(19):4848-56. PubMed ID: 10519395
    [Abstract] [Full Text] [Related]

  • 6. Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells.
    Li Y, Mao Y, Rosal RV, Dinnen RD, Williams AC, Brandt-Rauf PW, Fine RL.
    Int J Cancer; 2005 May 20; 115(1):55-64. PubMed ID: 15645452
    [Abstract] [Full Text] [Related]

  • 7. Bcl-xL inhibits p53- but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line.
    Schoop RA, Kooistra K, Baatenburg De Jong RJ, Noteborn MH.
    Int J Cancer; 2004 Mar 20; 109(1):38-42. PubMed ID: 14735465
    [Abstract] [Full Text] [Related]

  • 8. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
    Ruiz-Ruiz C, Muñoz-Pinedo C, López-Rivas A.
    Cancer Res; 2000 Oct 15; 60(20):5673-80. PubMed ID: 11059759
    [Abstract] [Full Text] [Related]

  • 9. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity.
    Jiang M, Yi X, Hsu S, Wang CY, Dong Z.
    Am J Physiol Renal Physiol; 2004 Dec 15; 287(6):F1140-7. PubMed ID: 15315938
    [Abstract] [Full Text] [Related]

  • 10. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
    Mashima T, Oh-hara T, Sato S, Mochizuki M, Sugimoto Y, Yamazaki K, Hamada J, Tada M, Moriuchi T, Ishikawa Y, Kato Y, Tomoda H, Yamori T, Tsuruo T.
    J Natl Cancer Inst; 2005 May 18; 97(10):765-77. PubMed ID: 15900046
    [Abstract] [Full Text] [Related]

  • 11. Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial-mediated mechanism.
    Gajate C, An F, Mollinedo F.
    Clin Cancer Res; 2003 Apr 18; 9(4):1535-45. PubMed ID: 12684430
    [Abstract] [Full Text] [Related]

  • 12. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J, Petak I, Szucs KS, Nagy K, Tillman DM, Houghton JA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6504-15. PubMed ID: 14695155
    [Abstract] [Full Text] [Related]

  • 13. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Weinrib L, Li JH, Donovan J, Huang D, Liu FF.
    Cancer Gene Ther; 2001 May 15; 8(5):352-60. PubMed ID: 11477455
    [Abstract] [Full Text] [Related]

  • 14. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S, Ng CP, Bonavida B.
    Clin Cancer Res; 2002 Mar 15; 8(3):836-45. PubMed ID: 11895917
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 17. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H.
    Breast Cancer Res Treat; 2010 Jan 15; 119(2):271-81. PubMed ID: 19238538
    [Abstract] [Full Text] [Related]

  • 18. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.
    Jiang M, Wei Q, Wang J, Du Q, Yu J, Zhang L, Dong Z.
    Oncogene; 2006 Jul 06; 25(29):4056-66. PubMed ID: 16491117
    [Abstract] [Full Text] [Related]

  • 19. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A, Gillissen B, Müller A, Normand G, Hemmati PG, Schuler M, Dörken B, Daniel PT.
    Oncogene; 2004 Jun 03; 23(26):4523-35. PubMed ID: 15064710
    [Abstract] [Full Text] [Related]

  • 20. Methioninase gene therapy with selenomethionine induces apoptosis in bcl-2-overproducing lung cancer cells.
    Yamamoto N, Gupta A, Xu M, Miki K, Tsujimoto Y, Tsuchiya H, Tomita K, Moossa AR, Hoffman RM.
    Cancer Gene Ther; 2003 Jun 03; 10(6):445-50. PubMed ID: 12768189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.